LEVONORGESTREL | N019897 | POPULATION COUNCIL
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
The Center for Reproductive Law & Policy et al - Citizen Petition FDA-2001-P-0123 · 52 docket documents The Center for Reproductive Law & Policy, on behalf of the American Public Health Association, the American Medical Women's Association, the Association of Reproductive Health Professionals, and fifty-eight other organizations, filed a citizen petition on February 14, 2001, requesting that the FDA e | Other | 2009-04-27 | Denied | — |
Citizen Petition from Duramed Research, Inc. FDA-2006-P-0348 · 5 docket documents Duramed Research, Inc., a subsidiary of Barr Pharmaceuticals, filed this citizen petition on July 14, 2006, requesting that the FDA require all Abbreviated New Drug Applications referencing Duramed's NDA No. 21-544 for Seasonale (0.03 mg ethinyl estradiol/0.15 mg levonorgestrel) to conduct bioequiva | 505(q) | 2009-03-24 | Withdrawn | Duramed Research, Inc. |
State of Wisconsin Department of Justic - Citizen Petition FDA-2006-P-0018 · 28 docket documents The State of Wisconsin, through its Attorney General, filed this citizen petition pursuant to 21 CFR §§ 10.25(a), 10.30, and 10.33 requesting that the FDA switch Plan B (levonorgestrel), an emergency contraceptive drug approved in 1999 for prescription use, and any equivalent drugs to over-the-count | Other | 2006-05-26 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.